| Literature DB >> 34216305 |
Gomaa Abdelrazek1, Kareem Mandour2, Mohammad Osama2, Khaled Elkhashab3.
Abstract
BACKGROUND: Atrial fibrillation (AF) occurs very frequently after coronary artery bypass grafting (CABG); it occurs in about 20-edictors can be used for the dedicatio40% of patients. It is associated with several adverse events. This study aimed to extrapolate a predictor for postoperative atrial fibrillation (POAF) occurrence which is reproducible and simple to be a part of routine echocardiography screening before CABG. This study included 89 patients scheduled for isolated coronary artery bypass surgery. History, clinical examination, and complete 2D echocardiography with LA speckle tracking analysis were done preoperatively. Patients were then followed up post-surgery for incidence of AF till discharge from the hospital. The patients were divided into 2 groups according to POAF occurrence.Entities:
Keywords: Left atrial dysfunction; Left atrial strain; Postoperative atrial fibrillation; Speckle tracking
Year: 2021 PMID: 34216305 PMCID: PMC8254834 DOI: 10.1186/s43044-021-00188-z
Source DB: PubMed Journal: Egypt Heart J ISSN: 1110-2608
Comparison between the study groups as regards the demographic data, clinical data, and medications
| Demographic data | No POAF | POAF | |
|---|---|---|---|
| Count | 61 | 28 | |
| 55.0 ± 6.4 | 58.7 ± 9.2 | 0.032 | |
| 31.5 ± 4.1 | 33.0 ± 3.1 | 0.093 | |
| Male gender | 40 (65.6%) | 18 (64.3%) | 0.906 |
| HTN | 38 (62.3%) | 20 (71.4%) | 0.401 |
| DM | 28 (45.9%) | 18 (64.3%) | 0.107 |
| Smoking | 32 (52.5%) | 16 (57.1%) | 0.681 |
| | |||
| Class 1 | 42 (68.9%) | 19 (67.9%) | 0.925 |
| Class 2 | 19 (31.1%) | 9 (32.1%) | |
| | |||
| Class 1 | 23 (37.7%) | 6 (21.4%) | 0.723 |
| Class 2 | 29 (47.5%) | 21 (75%) | |
| Class 3 | 9 (14.8%) | 1 (3.6%) | |
| | 76.4 ± 10.6 | 75.5 ± 10.8 | 0.708 |
| | 0.90 ± 0.25 | 0.94 ± 0.26 | 0.726 |
| Single vessel disease | 4 (6.6%) | 0 (0%) | 0.615 |
| Two-vessel disease | 12 (19.7%) | 11 (39.3%) | |
| Multi-vessel disease | 45 (73.7%) | 17 (60.7%) | |
| Aspirin | 61 (100%) | 28 (100%) | 1.000 |
| Statins | 46 (75.4%) | 19 (67.9%) | 0.456 |
| Nitrates | 56 (91.8%) | 16 (57.1%) | < 0.001 |
| Beta blockers | 50 (82%) | 20 (71.4%) | 0.260 |
| CCB | 4 (6.6%) | 2 (7.1%) | 1.000 |
| Digoxin | 0 (0%) | 1 (3.6%) | 0.315 |
| Diuretic | 14 (23%) | 3 (10.7%) | 0.173 |
| ACEI or ARB | 46 (75.4%) | 18 (64.3%) | 0.278 |
Comparison between the study groups as regards the operative and postoperative data
| Operative data | No POAF | POAF | |
|---|---|---|---|
| Count | 61 | 28 | |
| 72.4 ± 17.7 | 65.2 ± 12.6 | 0.056 | |
| 101.9 ± 19.7 | 94.3 ± 10.6 | 0.060 | |
| One | 4 (6.6%) | 0 (0%) | 0.388 |
| Two | 23 (37.7%) | 11 (39.3%) | |
| Three or more | 34 (55.7%) | 17 (60.7%) | |
| | 4.0 ± 0.5 | 4.0 ± 0.5 | 0.984 |
| | |||
| Inotropes | 42 (68.9%) | 21 (75%) | 0.554 |
| IABP | 3 (4.9%) | 4 (14.3%) | 0.200 |
| MI | 8 (13.1%) | 3 (10.7%) | 1.000 |
| Stroke | 2 (3.3%) | 4 (14.3%) | 0.075 |
| | 10.4 ± 2.3 | 11.5 ± 1.8 | 0.021 |
Comparison between the study groups as regards the echocardiographic measurements
| Echocardiographic data | No POAF | POAF | |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| LVEDD (mm) | 52.8 ± 4.8 | 51.7 ± 5.9 | 0.352 |
| LVESD (mm) | 34.5 ± 4.7 | 34.2 ± 4.9 | 0.785 |
| LVEF (%) | 61.8 ± 7.9 | 61.5 ± 5.3 | 0.879 |
| LA diameter (mm) | 36.3 ± 3.3 | 37.1 ± 2.5 | 0.219 |
| Mitral E velocity (cm/s) | 70.7 ± 17.7 | 55.8 ± 10.6 | < 0.001 |
| Mitral A velocity (cm/s) | 68.7 ± 18.3 | 68.6 ± 17.4 | 0.988 |
| Mitral E/A | 1.07 ± 0.35 | 0.89 ± 0.38 | 0.025 |
| Mitral E' velocity (cm) | 7.1 ± 2.4 | 5.5 ± 2.1 | 0.003 |
| Mitral A' velocity (cm) | 8.4 ± 2.2 | 8.9 ± 1.4 | 0.310 |
| Mitral S' velocity (cm) | 7.0 ± 1.6 | 6.8 ± 1.4 | 0.373 |
| Mitral E/E' | 10.6 ± 2.8 | 11.2 ± 3.2 | 0.413 |
| Mitral E deceleration (ms) | 201.6 ± 38.9 | 236.0 ± 27.8 | < 0.001 |
| PALS (%) | 32.9 ± 5.9 | 25.6 ± 6.1 | < 0.001 |
| LASRs (s−1) | 1.90 ± 0.71 | 1.27 ± 0.56 | < 0.001 |
| LASRe (s−1) | −1.69 ± 0.60 | −1.00 ± 0.45 | < 0.001 |
| LASRa (s−1) | −2.21 ± 0.59 | −1.21 ± 0.48 | < 0.001 |
The cut-off value of LA strain and strain rate for POAF and ROC curve analysis
| Cut-off value | SN % | SP % | PPV % | NPV % | Accuracy % | AUC | |
|---|---|---|---|---|---|---|---|
| PALS (%) ≤ 29.8 | 82.1% (63.1–93.9) | 80.3% (68.2–89.4) | 65.7% (47.8–80.9) | 90.7% (79.7–96.9) | 80.9% (71.2–88.5) | 0.800 (0.667–0.884) | < 0.001 |
| LASRs (s−1) ≤ 1.6 | 78.6% (59.1–91.7) | 65.6% (52.3–77.3) | 51.2% (35.5–66.7) | 87% (73.7–95.1) | 69.7% (59.0–79.0) | 0.749 (0.622–0.838) | < 0.001 |
| LASRe (s−1) ≤ −1.36 | 82.1% (63.1–93.9) | 73.8% (60.9–84.2) | 59% (42.1–74.4) | 90% (78.2–96.7) | 76.4% (66.2–84.8) | 0.824 (0.710–0.896) | < 0.001 |
| LASRa (s−1) ≤ −1.67 | 85.7% (67.3–96.0) | 90.2% (79.8–96.3) | 80% (61.4–92.3) | 93.2% (83.5–98.1) | 88.8% (80.3–94.5) | 0.908 (0.810–0.957) | < 0.001 |
ROC curve receiver operating characteristic curve, SN sensitivity, SP specificity, PPV positive predictive value, NPV negative predictive value, AUC area under the curve, 95% CI 95% confidence interval
Multivariate regression analysis for incidence of POAF
| Variable | Adjusted OR | 95% confidence interval for OR | ||
|---|---|---|---|---|
| Lower bound | Upper bound | |||
| 1.181 | 1.011 | 1.379 | 0.036 | |
| 0.069 | 0.004 | 1.170 | 0.064 | |
| 0.770 | 0.627 | 0.946 | 0.013 | |
| 0.855 | 0.151 | 4.829 | 0.859 | |
| 0.434 | 0.009 | 19.856 | 0.669 | |
| 3.476 | 1.207 | 12.186 | 0.022 | |
Fig. 1ROC curve analysis
Fig. 2Multivariate regression analysis for incidence of POAF